Fenofibrate prevents adipocyte hypertrophy and insulin resistance by increasing FA β-oxidation and intracellular lipolysis from visceral adipose tissue, showing that PPARα may be one of the major factors leading to decreased adipocyte size and improved insulin sensitivity [48]. Here, PPARA is linked to Insulin resistance.